Polycystic ovary syndrome: Focus on platelets and prothrombotic risk

Southern Medical Journal

Volumn 104, Issue 3, 2011, Pages 174-178

  Dasanu, Constantin A ^a   Clark III, Bernard A ^b   Ichim, Thomas E ^b   Alexandrescu, Doru T ^b  

^a Gothic Park   (United States)

^b NONE

Author keywords

polycystic ovary syndrome; procoagulant; prothrombotic risk; thrombocytosis

Indexed keywords

ALKALINE PHOSPHATASE; C REACTIVE PROTEIN; HEMOGLOBIN;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; LEUKOCYTOSIS; NEUTROPHIL COUNT; NEUTROPHILIA; OVARY POLYCYSTIC DISEASE; PROTEIN BLOOD LEVEL; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; THROMBOCYTOSIS; THROMBOSIS;

ADULT; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; HUMANS; LEUKOCYTOSIS; NEUTROPENIA; PLATELET AGGREGATION; PLATELET COUNT; POLYCYSTIC OVARY SYNDROME; THROMBOCYTOSIS; YOUNG ADULT;

EID: 79952187016     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e31820c0172     Document Type: Article

References (15)

1. Chang AY, Wild RA. Characterizing cardiovascular risk in women with polycystic ovary syndrome: more than the sum of its parts? Semin Reprod Med 2009;27:299-305.
2. Mak W, Dokras A. Polycystic ovarian syndrome and the risk of cardiovascular disease and thrombosis. Semin Thromb Hemost 2009; 35:613-620.
3. Snoep JD, Roest M, Barendrecht AD, et al. High platelet reactivity is associated with myocardial infarction in premenopausal women: a population-based case-control study. J Thromb Haemost 2010;8:906-913.
4. Rajendran S, Willoughby SR, Chan WP, et al. Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects. Atherosclerosis 2009;204:509-514.
5. Schneider DJ. Abnormalities of coagulation, platelet function, and fibrinolysis associated with syndromes of insulin resistance. Coron Artery Dis 2005;16:473-476. (Pubitemid 44365933)
6. Kebapcilar L, Taner CE, Kebapcilar AG, et al. High mean platelet volume, low-grade systemic coagulation and fibrinolytic activation are associated with androgen and insulin levels in polycystic ovary syndrome. Arch Gynecol Obstet 2009;280:187-193.
7. Dereli D, Ozgen G, Buyukkececi F, et al. Platelet dysfunction in lean women with polycystic ovary syndrome and association with insulin sensitivity. J Clin Endocrinol Metab 2003;88:2263-2268. (Pubitemid 36549906)
8. Yilmaz M, Biri A, Bukan N, et al. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Gynecol Endocrinol 2005;20:258-263. (Pubitemid 40897391)
9. Orio F Jr, Palomba S, Cascella T, et al. The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:2-5. (Pubitemid 40116624)
10. Ibáñez L, Jaramillo AM, Ferrer A, et al. High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception. Hum Reprod 2005;20:2457-2462. (Pubitemid 41226405)
11. Diamanti-Kandarakis E, Paterakis T, Kandarakis HA. Indices of lowgrade inflammation in polycystic ovary syndrome. Ann N Y Acad Sci 2006;1092:175-186. (Pubitemid 47092336)
12. Samy N, Hashim M, Sayed M, et al. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index. Dis Markers 2009;26:163-170.
13. González F, Rote NS, Minium J, et al. Evidence of proatherogenic inflammation in polycystic ovary syndrome. Metabolism 2009;58: 954-962.
14. Machin SJ, Briggs C. Mean platelet volume: a quick, easy determinant of thrombotic risk? J Thromb Haemost 2010;8:146-147.
15. Repaci A, Gambineri A, Pasquali R. The role of low-grade inflammation in the polycystic ovary syndrome. Mol Cell Endocrinol 2010;August 11 [Epub ahead of print].